Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS

Journal of Medicinal Chemistry

Volumn 40, Issue 13, 1997, Pages 1969-1976

  McDonnell, Nazli B ^a   De Guzman, Roberto N ^a   Rice, William G ^b   Turpin, Jim A ^b   Summers, Michael F ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTAMINE; DISULFIDE; DISULFIRAM; DITHIOCARBAMIC ACID; THIAMINE DISULFIDE; ZINC; ZINC FINGER PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG MIXTURE; DRUG POTENCY; NUCLEAR MAGNETIC RESONANCE; VIRUS INFECTION; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; CAPSID; CAPSID PROTEINS; CELLS, CULTURED; CYSTAMINE; DISULFIRAM; DITIOCARB; GENE PRODUCTS, GAG; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; THIAMINE; VIRAL PROTEINS; ZINC FINGERS;

EID: 0030980813     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970147+     Document Type: Article

References (76)

1. Dickson, C.; Eisnman, R.; Fan, R.; Hunter, E.; Teich, N. in RNA Tumor Viruses, 2nd ed.; Weiss, R., Ed.; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1985; Vols. 1 and 2.
2. Mervis, R. J.; Ahmad, N.; Lillehoj, E. P.; Raum, M. G.; Salazar, F. H. R.; Chan, H. W.; Venkatesan, S. The gag Gene Products of Human Immunodeficiency Virus Type 1: Alignment with the gag Open Reading Frame, Identification of Posttranslational Modifications, and Evidence for Alternative gag Precursors. J. Virol. 1988, 62, 3993-4002.
3. Henderson, L. E.; Bowers, M. A.; Sowder, R. C., II; Serabyn, S. A.; Johnson, D. G.; Bess, W., Jr.; Arthur, L. O.; Bryant, D. K.; Fenselau, C. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 1992, 66, 1856-1865.
4. Gelderblom, H. R. Assembly and Morphology of HIV: Potential Effect of Structure on Viral Function. AIDS 1991, 5, 617-637.
5. Hunter, E. Macromolecular interactions in the assembly of HIV and other retroviruses. Sem. Virol. 1994, 5, 71-83.
6. Wills, J.; Craven, R. Form, Function, and Use of Retroviral gag Proteins. AIDS 1991, 5, 639-654.
7. Dorfman, T.; Luban, J.; Goff, S. P.; Haseltine, W. A.; Göttlinger, H. G. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 1993, 67, 6159-6169.
8. Julian, N.; Demene, H.; Morellet, N.; Maigret, B.; Roques, B. P. Replacement of His23 by Cys in a zinc finger of HIV-1 NCp7 led to a change in 1H NMR-derived 3D structure and to a loss of biological activity. FEBS Lett. 1993, 331, 43-48.
9. Gorelick, R. J.; Chabot, D. J.; Alan, R.; Henderson, L. E.; Arthur, L. O. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 1993, 67, 4027-4036.
10. Gorelick, R. J.; Nigida, J.; Stephen, M.; Bess, J. W.; Arthur, L. O.; Henderson, L. E.; Alan, R. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 1990, 64, 3207-3211.
11. Aldovini, A.; Young, R. A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 1990, 64, 1920-1926.
12. Franke, E. K.; Yuan, H. E. H.; Bossolt, K. L.; Goff, S. P.; Luban, J. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J. Virol. 1994, 68, 5300-5305.
13. De Rocquigny, H.; Gabus, C.; Vincent, A.; Fournié-Zaluski, M.-C.; Roques, B.; Darlix, J.-L. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 6472-6476.
14. Aronoff, R.; Hajjar, A. M.; Linial, M. L. Avian retroviral RNA encapsidation: reexamination of functional 5′ RNA sequences and the role of nucleocapsid Cys-His motifs. J. Virol. 1993, 67, 178-188.
15. Barat, C.; Schatz, O.; Le Grice, S.; Darlix, J.-L. Analysis of the interactions of HIV1 replication primer tRNA-Lys,3 with nucleocapsid protein and reverse transcriptase. J. Mol. Biol. 1993, 231, 185-190.
16. Lapadat-Tapolsky, M.; De Rocquigny, H.; Van Gent, D.; Roques, B.; Plasterk, R.; Darlix, J.-L. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucl. Acids Res. 1993, 21, 831-839.
17. Darlix, J.-L.; Gabus, C.; Nugeyre, M.-T.; Clavel, F.; Barre-Sinoussi, F. Cis elements and Trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J. Mol. Biol. 1990, 216, 689-699.
18. Fu, W.; Rein, A. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 1993, 67, 5443-5449.
19. Berg, J. M. Potential metal-binding domains in nucleic acid binding proteins. Science 1986, 232, 485-487.
20. Henderson, L. E.; Copeland, T. D.; Sowder, R. C.; Smythers, G. W.; Oroslzan, S. Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J. Biol. Chem. 1981, 256, 8400-8406.
21. Méric, C.; Goff, S. P. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys - His box of the nucleocapsid protein. J. Virol. 1989, 63, 1558-1568.
22. Méric, C.; Gouilloud, E.; Spahr, P.-F. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His Boxes. J. Virol. 1988, 62, 3328-3333.
23. Méric, C.; Spahr, P.-F. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J. Virol. 1986, 60, 450-459.
24. Méric, C.; Darlix, J.-L.; Spahr, P.-F. It is Rous sarcoma virus protein p12 and not p19 that binds tightly to Rous sarcoma virus RNA. J. Mol. Biol. 1984, 173, 531-538.
25. South, T. L.; Kim, B.; Summers, M. F. 113Cd NMR studies of a 1:1 Cd adduct with an 18-residue zinc finger peptide from HIV-1 nucleic acid binding protein, p7. J. Am. Chem. Soc. 1989, 111, 395.
26. '26) South, T. L.; Blake, P. R.; Hare, D. R.; Summers, M. F. C-terminal retroviral-type zinc finger domain from the HIV-1 nucleocapsid protein is structurally similar to the N-terminal zinc finger domain. Biochemistry 1991, 30, 6342-6349.
27. South, T. L.; Summers, M. F.; Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC. Protein Sci. 1993, 2, 3-19.
28. South, T. L.; Kim, B.; Hare, D. R.; Summers, M. F. Zinc fingers and molecular recognition. Structure and nucleic acid binding studies of an HIV zinc finger-like domain. Biochem. Pharmacol. 1990, 40, 123-129.
29. Summers, M. F.; South, T. L.; Kim, B.; Hare, D. R. High-resolution structure of an HIV zinc fingerlike domain via a new NMR-based distance geometry approach. Biochemistry 1990, 29, 329-340.
30. Summers, M. F. Zinc finger motif for single-stranded nucleic acids? Investigations by nuclear magnetic resonance. J. Cell. Biochem. 1991, 45, 41-48.
31. Green, L. M.; Berg, J. M. A retroviral Cys-Xaa2-Cys-Xaa4-His-Xaa4-Cys peptide binds metal ions: Spectroscopic studies and a proposed three-dimensional structure. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 4047-4051.
32. Green, L. M.; Berg, J. M. Retroviral nucleocapsid protein-metal ion interactions: Folding and sequence variants. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 6403-6407.
33. Omichinski, J. G.; Clore, G. M.; Sakaguchi, K.; Appella, E.; Gronenborn, A. M. Structural characterization of a 39-residue synthetic peptide containing the two zinc binding domains from the HIV-1 p7 nucleocapsid protein by CD and NMR spectroscopy. FEBS Lett. 1991, 292, 25-30.
34. Summers, M. F.; Henderson, L. E.; Chance, M. R.; Bess, J. W. J.; South, T. L.; Blake, P. R.; Sagi, I.; Perez-Alvarado, G.; Sowder, R. C. I.; Hare, D. R.; Arthur, L. O. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1992, 1, 563-574.
35. 2+ complex formation analysis with electrospray mass spectrometry. FEBS Lett. 1992, 311, 259-262.
36. Surovoy, A.; Dannull, J.; Moelling, K.; Jung, G. Conformational and nucleic acid binding studies on the synthetic nucleocapsid protein of HIV-1. J. Mol. Biol. 1993, 229, 94-104.
37. Mély, Y.; De Rocquigny, H.; Morellet, N.; Roques, B. P.; Gérard, D. Zinc binding to the HIV-1 nucleocapsid protein: A thermodynamic investigation by fluorescence spectroscopy. Biochemistry 1996, 35, 5175-5182.
38. Mély, Y.; de Rocquigny, H.; Piémont, E.; Déméné, H.; Julían, N.; Fournié-Zaluski, M.-C.; Roques, B. P.; Gérard, D. Influence of the N- and C-terminal chains on the zinc-binding and conformational properties of the central zinc-finger structure of Moloney murine leukemia virus nucleocapsid protein: a steady-state and time-resolved fluorescence study. Biochim. Biophys. Acta 1993, 1161, 6-18.
39. Mély, Y.; Cornille, F.; Fournié-Zaluski, M.-C.; Darlix, J.-L.; Roques, B. P.; Gérard, D. Investigation of zinc-binding affinities of moloney murine leukemia virus nucleocapsid protein and its related zinc finger and modified peptides. Biopolymers 1991, 31, 899-906.
40. Phe binding: A steady-state and time resolved fluorescence study. Biophys. J. 1993, 65, 1513-1522.
41. Déméné, H.; Jullian, N.; Morellet, N.; de Rocquigny, H.; Cornille, F.; Maigret, B.; Roques, B. P. Three-dimensional 1H NMR structure of the nucleocapsid protein NCp10 of Moloney murine leukemia virus. J Biomol. NMR 1994, 4, 153-170.
42. Morellet, N.; Jullian, N.; De Rocquigny, H.; Maigret, B.; Darlix, J.-L.; Roques, B. P. Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J. 1992, 11, 3059-3065.
43. 1H NMR. J. Mol. Biol. 1994, 235, 287-301.
44. Chance, M. R.; Sagi, I.; Wirt, M. D.; Frisbie, S. M.; Scheuring, E.; Chen, E.; Bess, J. W., Jr.; Henderson, L. E.; Arthur, L. O.; South, T. L.; Perez-Alvarado, G.; Summers, M. F. Extended x-ray absorption fine structure studies of a retrovirus: Equine infectious anemia virus cysteine arrays are coordinated to zinc. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 10041-10045.
45. Rice, W. G.; Schaeffer, C. A.; Harten, B.; Villinger, F.; South, T. L.; Summers, M. F.; Henderson, L. E.; Bess, J. W., Jr.; Arthur, L. O.; McDougal, J. S.; Orloff, S. L.; Mendeleyev, J.; Kun, E. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 1993, 361, 473-475.
46. Rice, W. G.; Schaeffer, C. A.; Graham, L.; Bu, M.; McDougal, J. S.; Orloff, S. L.; Villinger, F.; Young, M.; Oroszlan, S.; Fesen, M. R.; Pommier, Y.; Mendeleyev, J.; Kun, E. The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 9721-9724.
47. Rice, W. G.; Turpin, J. A.; Schaeffer, C. A.; Graham, L.; Clanton, D.; Buckheit, R. W.; Zaharevitz, D.; Summers, M. F.; Wallqvist, A.; Covell, D. G. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J. Med. Chem. 1996, 39, 3606-3616.
48. Rice, W. G.; Supko, J. G.; Malspeis, L.; Buckheit, R. W., Jr.; Clanton, D.; Bu, M.; Grahm, L.; Schaeffer, C. A.; Turpin, J. A.; Domagala, J.; Gogliotti, R.; Bader, J. P.; Halliday, S. M.; Coren, L.; Sowder, R. C., II; Arthur, L. O.; Henderson, L. E. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 1995, 270, 1194-1197.
49. Rice, W. G.; Baker, D. C.; Schaeffer, C. A.; Graham, L.; Bu, M.; Terpening, S.; Clanton, D.; Schultz, R.; Bader, J. P.; Buckheit, R. W., Jr.; Field, L.; Singh, P. K.; Turpin, J. A. Inhibition of multiple phases of human immunodeficiency virus Type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Antimicrob. Agents Chemother. 1997, 41, 419-426.
50. Shailer, P.; Brodfuehrer, J.; Sedman, A.; Vassos, A. Proceedings: Fourth Conference on Retroviruses and Opportunistic Infections 1997, Abstract No. 229.
51. Rice, W. G.; Turpin, J. A.; Clanton, D.; Buckheit, R. W., Jr.; Summers, M. F.; McDonnell, N.; DeGuzman, R. N.; Covell, D. G.; Wallqvist, A.; Zalkow, L.; Bader, J. P.; Haugwitz, R. D.; Sausville, E. A. Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nature Medicine 1997, 3, 341-345.
52. Vandevelde, M.; Witvrouw, M.; Schmit, J.-C.; Sprecher, S.; DeClercq, E.; Tassignon, J. P. ADA, a Potential Anti-HIV Drug. AIDS Res. Hum. Retroviruses 1996, 12, 567-568.
53. Bergamini, A.; Ventura, L.; Mancino, G.; Capozzi, M.; Placido, R.; Salanitro, A.; Cappanolli, L.; Faggioli, E.; Stoler, A.; Rocchi, G. In Vitro inhibition of the replication of Human Immunodeficiency Virus Type 1 by β-Mercaptoethylamine (Cysteamine). J. Infect. Dis. 1996, 174, 214-218.
54. South, T. L.; Blake, P. R.; Sowder, R. C., III; Arthur, L. O.; Henderson, L. E.; Summers, M. F. The nucleocapsid protein isolated from HTV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistry 1990, 29, 7786.
55. 113Cd NMR Spectroscopy of Coordination Compounds and Proteins. Coord. Chem. Rev. 1988, 86, 43-134.
56. Shoji, S.; Furuishi, K.; Misumi, S.; Miyazaki, T.; Kino, M.; Yamataka, K. Thiamine Disulfide as a Potent Inhibitor of Human Immunodeficiency Virus (Type-1) Production. Biochem. Biophys. Res. Commun. 1994, 205, 967-975.
57. Yu, X.; Hathout, Y.; Fenselau, C.; Sowder, R. C., II; Henderson, L. E.; Rice, W. G.; Mendeleyev, J.; Kun, E. Specific disulfide formation in the oxidation of HIV-1 zinc finger protein nucleocapsid p7. Chem. Res. Toxicol. 1995, 8, 586-590.
58. Tummino, P. J.; Scholten, J. D.; Harvey, P. J.; Holler, T. P.; Maloney, L.; Gogliotti, R.; Domagala, J.; Hupe, D. The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 969-973.
59. Turpin, J. A.; Schaeffer, C. A.; Terpening, S. J.; Graham, L.; Bu, M.; Rice, W. G. Reverse Transcription of Human Immunodeficiency Virus Type 1 is Blocked by Retroviral Zinc Finger Inhibitors. Antiviral Chem. Chemother. 1997, 8, 60-69.
60. Turpin, J. A.; Terpening, S. J.; Schaeffer, C. A.; Yu, G.; Glover, C. J.; Felsted, R. L.; Sausville, E. A.; Rice, W. G. Inhibitors of Human Immunodeficiency Virus Type 1 Zinc Fingers Prevent Normal Processing of Gag Precursors and Result in the Release of Noninfectious Virus Particles. J. Virol. 1996, 70, 6180-6189.
61. Bergamini, A.; Capozzi, M.; Ghibelli, L.; Dini, L.; Salanitro, A.; Milanese, G.; Wagner, T.; Beninati, S.; Pesce, C. D.; Amici, C.; Rocchi, G. Cystamine Potently Suppresses In Vitro HIV Replica tion in Acutely and Chronically Infected Human Cells. J. Clin. Invest. 1994, 93, 2251-2257.
62. Ho, W.-Z.; Zhu, X.-H.; Song, L.; Lee, H.-R.; Cutilli, J. R.; Douglas, S. D. Cystamine Inhibits HIV Type 1 Replication in Cells of Monocyte/Macrophage and T Cell Lineages. AIDS Res. Hum. Retroviruses 1995, 11, 451-459.
63. Goetzsche, P. C. Dithiocarb in HIV Infection. Lancet 1988, 8618, 1024.
64. Gallant, D. M.; Head-Durham, R. Antabuse (disulfiram) and AIDS. Alcohol.: Clin. Exp. Res. 1991, 15, 900-901.
65. Gessner, P. K.; Gessner, T. Disulfiram and its metabolite diethyldithiocarbamate: pharmacology and status in the treatment of alcoholism, HIV infections, AIDS and heavy metal toxicity; Gessner, P. K., Gessner, T., Eds.; Chapman & Hall: London, 1992; p 452.
66. Hersh, E. M.; Brewton, G.; Abrams, D.; Bartlett, J.; Galpin, J.; Gill, P.; Gorter, R.; Gottlieb, M.; Jonikas, J. J.; Landesman, S. Dithiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. J. Am. Med. Assoc. 1991, 266, 795-796.
67. Hersh, E. M.; Funk, C. Y.; Petersen, E. A.; Ryschon, K. L.; Mosier, D. E. Effective therapy of the LP-BM5 murine retrovirus induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate. AIDS Res. Hum. Retroviruses 1991, 7, 553-561.
68. Bihari, B.; Fleischer, T.; Devine, J.; Seaman, J. D. Disulfiram as an immunomodulating agent-follow up; Bihari, B., Fleischer, T., Devine, J., Seaman, J. D., Eds.; International Conference on AIDS, 1989; Vol. 5, pp 661.
69. Sunderman, F. W. S. The Extended Therapeutic Role of Dithiocarb (Sodium Diethyldithiocarbamate) from Nickel poisoning To AIDS. Ann. Clin. Lab. Sci. 1992, 22, 245-248.
70. Sunderman, F. W. S. Therapeutic Properties of Sodium Diethyldithiocarbamate: Its role as an inhibitor in the progression of AIDS. Ann. Clin. Lab. Sci. 1991, 21, 70-81.
71. Nagiel-Ostaszewski, I.; Lau-Cam, C. A. Protection by pantethine, pantothenic acid and cystamine against carbon tetrachloride-induced hepatotoxicity in the rat. Res. Commun. Chem. Pathol. Pharmacol. 1990, 67, 289-292.
72. Vasin, M. V.; Chernov, I. N.; Semenova, L. A. Antiradiation properties of radioprotectors, immunomodulators and agents affecting tissue metabolism in fractionated irradiation. Radiobiologiya 1991, 31, 271-275.
73. Kozubic, A.; Pospisil, M.; Netikova, J. Possibilities of the combined use of non-steroidal anti-inflammatory drugs and sulphidril compounds in radioprotection. Strahlenther. Onkol. 1991, 167, 186-190.
74. Knoepfelmacher, M.; Rocha, R.; Saldago, L. R.; Semer, M.; Voss, D.; Wajchenberg, B. L.; Liberman, B. Nephropathic cystinosis: report of 2 cases and review of the literature. Revista Da Associacao Medica Brasiliera 1994, 40, 43-46.
75. Rice, W. G.; Bader, J. P. Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals; Rice, W. G., Bader, J. P., Eds.; Academic Press: San Diego, 1995; Vol. 33, pp 389-438.
76. Turpin, J. A.; Schaeffer, C. A.; Bu, M.; Graham, L.; Buckheit, R. W., Jr.; Clanton, D.; Rice, W. G. HIV-1 Replication is Unaffected by Human Secretory Leukocyte Protease Inhibitor. Antiviral Res. 1996, 29, 269-277.